abvcpharma.com (ABVC): Net earnings per share growth forecast for next year
In the niche natural medicine environment, ABVC BioPharma is resisting the expansion of corporate behemoths. The projected growth rate of net earnings per share demonstrates current volatility, where 0.00 is the relevant value of the indicator. The business model relies on full outsourcing of production and testing through external contractors. The company is currently scaling its line of plant-based treatments for cancer and depression.
Comprehensive metric breakdowns and analytics for abvcpharma.com (ABVC)
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- company book value details:
- company total debt and liquidity indicators:
- earnings and valuation multiples information:
ABVC - Net Financial Result|Expected Profit ABVC BioPharma|ABVC - Market Cap to Earnings|Future Price to Earnings ABVC BioPharma|ABVC - Market Cap to Earnings and Growth Ratio|EV/EBITDA Multiple ABVC BioPharma|ABVC - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) ABVC BioPharma|ABVC - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months abvcpharma.com|ABVC - Earnings per share increase in current year|Net earnings per share growth forecast for next year ABVC BioPharma
Comprehensive company analysis:ABVC BioPharma Inc
For long-term investors, this indicator serves as a leading signal for assessing operational efficiency and the risks of failing to meet targets. The metric measures the expected percentage change in earnings per share for the coming year, reflecting the professional community's consensus forecast. By analyzing forward EPS dynamics, one can evaluate how the success of ABVC BioPharma (ABVC) oncology drug clinical trials will impact the business's future capitalization.
Competitor analysis for ABVC BioPharma
HLN (Haleon Group) - Earnings growth forecast for next year|Expected net earnings per share growth next year Kenvue Health KVUE|Net earnings per share growth forecast for next year Verona Pharma plc (VRNA)|MENS (jyongbio.com) - Expected earnings per share trend next year|Earnings growth forecast for next year LGND (Ligand)|Earnings growth forecast for next year Amneal Pharmaceuticals, Inc. AMRX|Perrigo Company - Earnings growth forecast for next year|ALVO: Net earnings per share growth forecast for next year|LQDA (Liquidia Corporation) - Expected earnings per share growth for next year|GLPG (glpg.com) - Net earnings per share growth forecast for next year|ANIP (ANI Pharmaceuticals, Inc.) - Earnings growth forecast for next year|Expected earnings per share growth for next year MannKind Corp (MNKD)|Expected earnings per share growth for next year AMPH (Amphastar)|PCRX (Pacira Corp) - Expected earnings per share trend next year|Earnings growth forecast for next year SPRY (ARS Pharmaceuticals)|theravance.com - Net earnings per share growth forecast for next year|Aquestive Therapeutics, Inc. - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year scPharmaceuticals Inc. SCPH|tectonictx.com (TECX) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Tonix Pharmaceuticals Holding (TNXP)|Net earnings per share growth forecast for next year SXT Pharmaceuticals|Eupraxia Pharma - Net earnings per share change forecast for next year|Earnings growth forecast for next year BHST|EXOZ (Invizyne Technologies) - Expected earnings per share trend next year|Earnings growth forecast for next year ORMP (Oramed Pharmaceuticals Inc.)|Earnings growth forecast for next year Entera Bio Ltd ENTX|HYFT - Net earnings per share growth forecast for next year|Expected earnings per share trend next year CPIX (cumberlandpharma.com)|Quantum BioPharma (QNTM) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year FibroGen Inc|TELO (Telomir Pharma) - Earnings growth forecast for next year|Earnings growth forecast for next year Rani Therapeutics Inc|Earnings growth forecast for next year SNYR|Earnings growth forecast for next year rallybio.com (RLYB)|Earnings growth forecast for next year LEXX (Lexaria Bioscience Corp.)|Pulmatrix Inc - Net earnings per share growth forecast for next year|PTHL: Expected earnings per share growth for next year|APM: Net earnings per share growth forecast for next year|LYRA: Earnings growth forecast for next year|Expected earnings per share growth for next year Impact BioMedical, Inc.|Net earnings per share growth forecast for next year TNF Pharmaceuticals Inc.|cbdMD Corp - Net earnings per share change forecast for next year|Earnings growth forecast for next year PRFX|CYTO (altamiratherapeutics.com) - Expected earnings per share trend next year|Earnings growth forecast for next year LIPO (Lipella Pharmaceuticals)|Earnings growth forecast for next year optinose.com OPTN|PIRS - Net earnings per share growth forecast for next year|Expected earnings per share trend next year PROC (Procaps Group)|Petros (PTPI) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Qilian International Corp|SLRN (Acelyrin, Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year tffpharma.com
